Hussein Sara M, Sharaf Basel A, Mardini Samir, Gibreel Waleed
Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
J Clin Med. 2025 Jun 10;14(12):4116. doi: 10.3390/jcm14124116.
Auricular reconstruction poses significant surgical challenges in congenital and post-traumatic cases. Porous polyethylene (PPE) implants have emerged as a biocompatible alternative to the traditional autologous rib cartilage frames, offering less morbidity and a potentially stable framework. Here, we summarize the current evidence of the use of PPE auricular implants. : A literature search was performed in accordance with PRISMA guidelines across several databases. Studies reporting outcomes of PPE implants in auricular reconstruction were included. Data were extracted on patient characteristics, operative details, and complication rates, along with any required interventions to address complications. Complications were classified as minor or major based on their management strategy. : Of 544 screened studies, 14 studies representing 1036 patients were included. PPE implant use was generally linked with favorable esthetic outcomes and high patient satisfaction (80%). Study-to-study variation in complication rates was notable, with some complication rates as high as 44% in the early 1990s. By the early 2000s, advancements in surgical methods-particularly the use of temporoparietal fascia (TPF) flaps and other flaps for optimal soft tissue coverage-had markedly reduced complication rates, with recent studies reporting rates as low as 7%. Implant exposure (6.7%) and implant fractures (ranging from 1.6% to 3.2%) were the most frequently reported problems. : PPE auricular implants, despite decades of availability, have faced limited global adoption due to concerns over complications and longevity. Advances in surgical techniques have significantly reduced complication rates (<7%), making PPE implants a viable early intervention with favorable esthetics and negligible donor-site morbidity.
耳廓重建在先天性和创伤后病例中带来了重大的手术挑战。多孔聚乙烯(PPE)植入物已成为传统自体肋软骨框架的生物相容性替代品,具有较低的发病率和潜在的稳定框架。在此,我们总结了使用PPE耳廓植入物的当前证据。:根据PRISMA指南在多个数据库中进行了文献检索。纳入了报告PPE植入物在耳廓重建中结果的研究。提取了患者特征、手术细节和并发症发生率的数据,以及处理并发症所需的任何干预措施。根据管理策略将并发症分为轻微或严重。:在544项筛选研究中,纳入了14项研究,代表1036名患者。PPE植入物的使用通常与良好的美学效果和较高的患者满意度(80%)相关。研究之间并发症发生率的差异显著,在20世纪90年代初,一些并发症发生率高达44%。到21世纪初,手术方法的进步——特别是使用颞顶筋膜(TPF)皮瓣和其他皮瓣进行最佳软组织覆盖——显著降低了并发症发生率,最近的研究报告发生率低至7%。植入物暴露(6.7%)和植入物骨折(范围从1.6%到3.2%)是最常报告的问题。:尽管PPE耳廓植入物已经有几十年的应用历史,但由于对并发症和使用寿命的担忧,在全球范围内的采用有限。手术技术的进步显著降低了并发症发生率(<7%),使PPE植入物成为一种可行的早期干预措施,具有良好的美学效果且供区发病率可忽略不计。